|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent CYTH insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why CYTH insider buys are important for investors to follow.
Date | Insider | Price | Amount |
8-1-2023 Insider Buy |
Rafael Holdings, Inc. >10% Owner |
$1.25
CAGR »
|
$5,000,000.00 4,000,000 shares |
4-20-2023 Insider Buy |
Jeffrey Tate Chief Operating Officer |
$0.71
CAGR »
|
$21,258.11 29,941 shares |
4-20-2023 Insider Buy |
Francis Patrick Ostronic Director |
$0.71
CAGR »
|
$42,515.51 59,881 shares |
4-20-2023 Insider Buy |
Markus Sieger Director |
$0.71
CAGR »
|
$42,515.51 59,881 shares |
4-20-2023 Insider Buy |
N. Scott Fine Chief Executive Officer |
$0.71
CAGR »
|
$212,575.42 299,402 shares |
9-21-2022 Insider Buy |
Francis Patrick Ostronic Director |
$1.76
CAGR »
|
$8,800.00 5,000 shares |
5-20-2022 Insider Buy |
Francis Patrick Ostronic Director |
$2.04
CAGR »
|
$10,199.02 5,000 shares |
5-16-2022 Insider Buy |
Jeffrey Tate Chief Operating Officer |
$2.12
CAGR »
|
$6,354.00 3,000 shares |
4-29-2022 Insider Buy |
Jeffrey Tate Chief Operating Officer |
$2.64
CAGR »
|
$5,279.39 2,000 shares |
3-29-2022 Insider Buy |
Markus Sieger Director |
$2.73
CAGR »
|
$27,300.00 10,000 shares |
1-24-2022 Insider Buy |
Francis Patrick Ostronic Director |
$3.75
CAGR »
|
$7,500.00 2,000 shares |
1-19-2022 Insider Buy |
N. Scott Fine Chief Executive Officer |
$3.89
CAGR »
|
$19,450.00 5,000 shares |
1-19-2022 Insider Buy |
Francis Patrick Ostronic Director |
$4.00
CAGR »
|
$4,528.00 1,132 shares |
1-14-2022 Insider Buy |
Francis Patrick Ostronic Director |
$4.00
CAGR »
|
$6,924.00 1,731 shares |
1-14-2022 Insider Buy |
Francis Patrick Ostronic Director |
$4.00
CAGR »
|
$8,548.00 2,137 shares |
12-15-2021 Insider Buy |
N. Scott Fine Chief Executive Officer |
$3.89
CAGR »
|
$19,450.00 5,000 shares |
12-15-2021 Insider Buy |
Francis Patrick Ostronic Director |
$3.90
CAGR »
|
$11,700.00 3,000 shares |
12-10-2021 Insider Buy |
Francis Patrick Ostronic Director |
$4.40
CAGR »
|
$22,000.00 5,000 shares |
12-3-2021 Insider Buy |
Francis Patrick Ostronic Director |
$4.75
CAGR »
|
$4,104.00 864 shares |
12-1-2021 Insider Buy |
Francis Patrick Ostronic Director |
$5.00
CAGR »
|
$25,000.00 5,000 shares |
10-29-2021 Insider Buy |
Francis Patrick Ostronic Director |
$5.90
CAGR »
|
$5,900.00 1,000 shares |
9-15-2021 Insider Buy |
N. Scott Fine Chief Executive Officer |
$6.35
CAGR »
|
$31,750.00 5,000 shares |
4-12-2021 Insider Buy |
Francis Patrick Ostronic Director |
$7.00
CAGR »
|
$35,000.00 5,000 shares |
3-29-2021 Insider Buy |
Jeffrey Tate Chief Operating Officer |
$7.50
CAGR »
|
$15,000.00 2,000 shares |
3-29-2021 Insider Buy |
Francis Patrick Ostronic Director |
$7.53
CAGR »
|
$22,600.00 3,000 shares |
3-29-2021 Insider Buy |
Sharon Hemond Hrynkow Chief Scientific Officer |
$7.46
CAGR »
|
$7,460.00 1,000 shares |
3-29-2021 Insider Buy |
Joshua M. Fine Chief Financial Officer |
$7.40
CAGR »
|
$370.00 50 shares |
3-29-2021 Insider Buy |
Markus Sieger Director |
$8.10
CAGR »
|
$81,000.00 10,000 shares |
1-26-2021 Insider Buy |
Markus Sieger Director |
$6.36
CAGR »
|
$63,634.40 10,000 shares |
Also See: Institutional Holders of CYTH
Also See: SEC filings
Below we present the annualized performance delivered by CYTH stock since 8-1-2023 (the date of the most recent
insider purchase). The performance of the investment from the time CYTH insider buying occurred is the ultimate
test of whether insiders were right about CYTH being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/02/2023 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$1.49 |
|
End price/share: |
$1.26 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-15.44% |
|
Annualized Gain: |
-21.34% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,456.00 |
|
Years: |
0.72 |
|
CYTH Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent CYTH insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CYTH
|
|